Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles – development, characterisation, and in vitro assessment of bioactivity for cardiac applications

References

• Bonafè, F., et al., 2014. Hyaluronan and cardiac regeneration. Journal of biomedical science, 21(1). DOI:10.1186/s12929-014-0100-4
   PubMed Web of Science ®Google Scholar
• Burchfield, J. S., Xie, M., and Hill, J. A., 2013. Pathological ventricular remodeling. Circulation, 128(4), 388–400.
   PubMed Web of Science ®Google Scholar
• Burdick, J.A., et al., 2013. Acellular biomaterials: an evolving alternative to cell-based therapies. Science translational medicine, 5(176), 176ps4.
   PubMed Web of Science ®Google Scholar
• Burdick, J.A. and Prestwich, G.D., 2011. Hyaluronic acid hydrogels for biomedical applications. Advanced materials, 23, H41–H56.
   PubMed Web of Science ®Google Scholar
• Cai, S., et al., 2005. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials, 26(30), 6054–6067.
   PubMed Web of Science ®Google Scholar
• Caplice et al., 2018. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI). American Heart Journal, 200, 110–117. doi: 10.1016/j.ahj.2018.03.018
   Google Scholar
• Clark, A., et al., 2014. Retention of insulin-like growth factor I bioactivity during the fabrication of sintered polymeric scaffolds. Biomedical materials, 9(2), 025015.
   PubMed Web of Science ®Google Scholar
• Conti, E., et al., 2008. Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option? Cardiovascular & hematological agents in medicinal chemistry, 6(4), 258–271.
   PubMedGoogle Scholar
• Darr, A. and Calabro, A., 2009. Synthesis and characterization of tyramine-based hyaluronan hydrogels. Journal of materials science. Materials in medicine, 20(1), 33–44.
   PubMed Web of Science ®Google Scholar
• Dolan, E. B., et al., 2019. A bioresorbable biomaterial carrier and passive stabilization device to improve heart function post-myocardial infarction. Materials science and engineering: C, 103, 109751.
   PubMed Web of Science ®Google Scholar
• Dolan, E. B., et al., 2018. A dvanced M aterial Cath eter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogels. Journal of biomaterials applications, 33(5), 681–692.
   PubMed Web of Science ®Google Scholar
• Ellison, G.M., et al., 2011. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. Journal of the American College of Cardiology, 58(9), 977–986.
   PubMed Web of Science ®Google Scholar
• Hastings, C.L., et al., 2015. Drug and cell delivery for cardiac regeneration. Advanced drug delivery reviews, 84, 85–106.
   PubMed Web of Science ®Google Scholar
• Ibáñez, B., et al., 2015. Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American college of cardiology, 65(14), 1454–1471.
   PubMed Web of Science ®Google Scholar
• Jaklenec, A., et al., 2008. Sequential release of bioactive IGF-I and TGF-β 1 from PLGA microsphere-based scaffolds. Biomaterials, 29(10), 1518–1525.
   PubMed Web of Science ®Google Scholar
• Jiang, G., et al., 2002. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. Journal of controlled release, 79(1–3), 137–145.
   PubMed Web of Science ®Google Scholar
• Jorgensen, L., et al., 2009. Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients. Expert opinion on drug delivery, 6(11), 1219–1230.
   PubMed Web of Science ®Google Scholar
• Kato, N., Nakanishi, K., and Nemoto, K., 2009. Efficacy of HGF gene transfer for various nervous injuries and disorders. Central nervous system agents in medicinal chemistry, 9(4), 300–306.
   PubMedGoogle Scholar
• Koudstaal, S., et al., 2014. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. Journal of cardiovascular translational research, 7(2), 232–241.
   PubMed Web of Science ®Google Scholar
• Linke, A., et al., 2005. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proceedings of the national academy of sciences, 102(25), 8966–8971.
   PubMed Web of Science ®Google Scholar
• Luginbuehl, V., et al., 2013. Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep. European journal of pharmaceutics and biopharmaceutics: official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.v, 85(1), 99–106.
   PubMed Web of Science ®Google Scholar
• Lundblad, R. L., 2007. Biochemistry and molecular biology compendium. Boca Raton, FL: CRC Press.
   Google Scholar
• Makadia, H.K. and Siegel, S.J., 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (basel), 3(3), 1377–1397.
   PubMed Web of Science ®Google Scholar
• Meinel, L., et al., 2001. Stabilizing insulin-like growth factor-I in poly (D, L-lactide-co-glycolide) microspheres. Journal of controlled release, 70(1–2), 193–202.
   PubMed Web of Science ®Google Scholar
• O'Neill, H.S., et al., 2016. Biomaterial-enhanced cell and drug delivery: lessons learned in the cardiac field and future perspectives. Advanced materials, 28(27), 5648–5661.
   PubMed Web of Science ®Google Scholar
• O'Neill, H.S., et al., 2018. A collagen cardiac patch incorporating alginate microparticles permits the controlled release of hepatocyte growth factor and insulin-like growth factor-1 to enhance cardiac stem cell migration and proliferation. Journal of tissue engineering and regenerative medicine, 12, e384–e394.
   PubMed Web of Science ®Google Scholar
• O'Sullivan et al., 2011. Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction. Circulation: Cardiovascular Intervention 4 (4), 327–335. doi: 10.1161/CIRCINTERVENTIONS.110.960765
   Google Scholar
• Pulavendran, S., et al., 2010. Hepatocyte growth factor incorporated chitosan nanoparticles differentiate murine bone marrow mesenchymal stem cell into hepatocytes in vitro. IET nanobiotechnology, 4(3), 51–60.
   PubMed Web of Science ®Google Scholar
• Putney, S.D., 1998. Encapsulation of proteins for improved delivery. Current opinion in chemical biology, 2(4), 548–552.
   PubMed Web of Science ®Google Scholar
• Ruvinov, E., Leor, J., and Cohen, S., 2011. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials, 32(2), 565–578.
   PubMed Web of Science ®Google Scholar
• Sharma, S., et al., 2015. PLGA-based nanoparticles: a new paradigm in biomedical applications. TrAC trends in analytical chemistry, 80, 30–40.
   Web of Science ®Google Scholar
• Shive, M.S. and Anderson, J.M., 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced drug delivery reviews, 28(1), 5–24.
   PubMed Web of Science ®Google Scholar
• Sohma, Y., et al., 2008. Comparative properties of insulin-like growth factor 1 (IGF-1) and [Gly7D-Ala]IGF-1 prepared by total chemical synthesis. Angewandte chemie international edition, 47(6), 1102–1106.
   PubMed Web of Science ®Google Scholar
• Song, H.-P., et al., 2018. PI3K–AKT pathway protects cardiomyocytes against hypoxia-induced apoptosis by MitoKATP-mediated mitochondrial translocation of pAKT. Cellular physiology and biochemistry, 49(2), 717–727.
   PubMedGoogle Scholar
• Torella, D., et al., 2004. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circulation research, 94(4), 514–524.
   PubMed Web of Science ®Google Scholar
• Ugwu, S.O. and Apte, S.P., 2004. The effect of buffers on protein conformational stability. Pharmaceutical technology, 28, 86–109.
   Google Scholar
• Urbanek, K., et al., 2005. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circulation research, 97(7), 663–673.
   PubMed Web of Science ®Google Scholar
• Varde, N.K. and Pack, D.W., 2004. Microspheres for controlled release drug delivery. Expert opinion on biological therapy, 4(1), 35–51.
   PubMed Web of Science ®Google Scholar
• Xie, Y., 2012. The nanobiotechnology handbook. New York: CRC Press.
   Google Scholar
• Xu, W., et al., 2015. Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer. International Journal of pharmaceutics, 496(2), 332–341.
   PubMed Web of Science ®Google Scholar
• Yancy, C.W., et al., 2013. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 128(16), 1810–1852.
   PubMed Web of Science ®Google Scholar
• Ye, M., Kim, S., and Park, K., 2010. Issues in long-term protein delivery using biodegradable microparticles. Journal of controlled release, 146(2), 241–260.
   PubMed Web of Science ®Google Scholar